Endometriosis is a chronic condition that affects more than 1 in 10 U.S. women between the ages of 15 and 44. Yet, getting a diagnosis can take several years. Symptoms often overlap with other conditions, and diagnosis may involve a medical exam, imaging tests and sometimes surgery.
But blood tests may offer another way to check for endometriosis without surgery. There are a few blood tests for endometriosis that are available and several blood-based testing options are in the works. But it’s important to note that no blood tests have been cleared or approved by the Food and Drug Administration (FDA) as a screening tool for endometriosis.
So, should you consider a blood test for endometriosis? Here’s what you need to know .
1. Endometriosis can take years to diagnose
Endometriosis occurs when endometrium tissue similar to the lining of the uterus grows outside the uterus. This can cause inflammation, pelvic pain and scar tissue. Symptoms can vary from person to person.
Common symptoms of endometriosis include:
- Severe pelvic pain
- Painful menstrual cramps
- Heavy menstrual bleeding or bleeding between periods
- Painful bowel movements or urination
- Pain during or after sex
- Infertility
- Fatigue, bloating, nausea or diarrhea around the time of menstruation
Josh Hurwitz, M.D., a reproductive endocrinologist and infertility specialist, said that diagnosing endometriosis can be difficult because symptoms can vary and often overlap with other conditions, including fibroids, adenomyosis, gastrointestinal disorders and pelvic floor dysfunction.
Hurwitz also noted that imaging tools, such as ultrasound and MRI, may identify some forms of endometriosis but can miss small areas of tissue or growths on the surface of organs. “Historically, surgical laparoscopy has provided the most definitive diagnosis, which means patients can spend years managing pain and symptoms before reaching that point,” he explained.
2. Blood tests could change the diagnostic process for endometriosis
Endometriosis blood tests look at specific biomarkers, which are measurable substances in the body.. Biomarkers that could be a sign of endometriosis can include microRNAs, proteins and steroid hormones. Some blood tests may also use other factors, such as a person’s age and body mass index (BMI) for example, to help predict whether they have endometriosis. But not all blood tests use the same biomarkers or approach.
Blood tests may add another tool to the diagnostic process, but they don’t remove the need for further evaluation. “[Blood tests are] meant to complement a patient's symptoms, medical history and imaging rather than replace a full clinical evaluation,” Hurwitz said.
More research is needed to assess the accuracy of these tests in everyday medical care and how well they perform across different patient groups.
3. What blood tests for endometriosis are available?
There are two commercially available blood tests for endometriosis in the United States: HerResolve and The EndomTest. Both tests use blood samples to measure biomarkers associated with the condition but use different approaches.
HerResolve, developed by HerAnova Lifesciences, combines three microRNAs, three proteins and one steroid hormone with patient information to help detect endometriosis.
The EndomTest is a blood test that combines two blood biomarkers — brain-derived neurotrophic factor (BDNF) and cancer antigen 125 (CA125) — and a person’s medical history to generate a result.
4. Results are promising, but more research is necessary to confirm accuracy
In one small study, HerResolve achieved 80% sensitivity (how well a medical test correctly identifies people who actually have a condition), 97.5% specificity (how often a test can correctly identify people who don’t have a condition) and 94.4% overall accuracy. In another study, EndomTest demonstrated 100% specificity and 43% sensitivity, with an overall accuracy rate of 46.2%.
While blood tests for endometriosis have the potential to help women get an endometriosis diagnosis, more research is needed to understand how well they perform in different patient populations and clinical settings.
“This is a start to noninvasive endometriosis diagnostic testing but by no means is it a finished product,” Hurwitz said.
5. Blood tests for endometriosis aren’t FDA-approved or FDA-cleared yet
No endometriosis blood test has received FDA approval or clearance.
HerResolve is available through select reproductive health clinics and home-collection services, with the company describing it as a laboratory-developed test (LDT). This means it has not received FDA clearance or approval.
The EndomTest is not FDA-cleared and is laboratory validated under Clinical Laboratory Improvement Amendments (CLIA) requirements. CLIA certification pertains to laboratory quality and testing standards.
If you’re considering an endometriosis blood test, ask your clinician what these tests can tell you and how the results might affect your care.
6. Who can get tested, and will insurance cover it?
Requirements for each test may vary, so be sure to check the manufacturer’s current requirements and talk to your clinician before changing your prescribed medications.
Because endometriosis blood tests are not yet FDA-cleared or -approved, patients may need to pay out of pocket, although they can use their HSA or FSA funds. “Even after FDA clearance or approval, insurers can make their own coverage decisions and may ask for evidence that a test improves clinical care, not simply that it performs accurately,” Hurwitz said.
7. Could endometriosis blood tests help close gaps in endometriosis diagnosis?
Black women can face delayed diagnoses, along with barriers to specialty care and differences in how symptoms are recognized. With the limited research on endometriosis blood tests, there’s uncertainty about how this diagnostic tool will improve outcomes for this patient population.
In the HerResolve study, its 80-person validation group included only nine Black women, and just one had confirmed endometriosis.
“It will be especially important to validate these tests in large, diverse patient populations before assuming they perform equally well across racial and ethnic groups,” Hurwitz said.
Endometriosis blood tests show potential for improved outcomes, but they’re not quite there yet
A less invasive diagnostic option for endometriosis could benefit people experiencing unexplained pelvic pain and other possible symptoms of endometriosis. However, it’s important to understand what the current evidence supports, what it lacks and how to use it alongside other diagnostic tests.
Talk with your clinician about your symptoms, testing options and whether a blood test for endometriosis is right for you.





Stories We Love
Support Our Mission





















